19 min listen
USCAP 2021 Long Course: Biomarkers of Response to Check Point Inhibitors - beyond PD-L1
FromModPath Chat
USCAP 2021 Long Course: Biomarkers of Response to Check Point Inhibitors - beyond PD-L1
FromModPath Chat
ratings:
Length:
17 minutes
Released:
Apr 27, 2021
Format:
Podcast episode
Description
In this fourth and final episode of our special series covering this year’s USCAP Long Course on lung disease, our guest, Dr. Lynette Sholl, chief of pulmonary pathology at the Brigham and Women Hospital discusses her presentation on "Biomarkers of Response to Checkpoint Inhibitors". Dr. Sholl touches upon the potential role of CD8+ T cell count, Multiplex IF based spatial profiling and novel genomic determinants as markers beyond PD-L1. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.
Released:
Apr 27, 2021
Format:
Podcast episode
Titles in the series (58)
COVID-19 pulmonary pathology in cross Atlantic pandemic epicenters: A discussion with Dr. Borczuk of New York Presbyterian Hospital- Weill Cornell Medicine on his team findings in sixty eight COVID-19 autopsies, performed early on during the pandemic, at 3 institutions in heavily hit areas (2 USA, 1 Italy). by ModPath Chat